Products
AI AGENTS
INTELLIGENCE SUITE
API, MCP & INTEGRATION
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
Patsnap Eureka Platform
IP Search Agents
IP Drafting Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
Materials Agents
SEP Agents
Patsnap Eureka Desktop
BetaAnalytics
IP IntelligenceHiro for Analytics
Synapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisProfessional Services
Open Platform
Developer Center
Customer Stories
Newsroom
Blog
2026 R&D Benchmark Report
Glossary
Free tools
NEWWebinars & Training
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
No credit card required
Already have an account? Log In
To start using Patsnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Ultrafast laser microfabrication patent landscape 2026: femtosecond & picosecond laser trends across semiconductor packaging, biomedical, TPP, and beam shaping.
Article | Report Ex vivo lentiviral gene therapy for Wiskott-Aldrich syndrome and primary immunodeficiencies: vector design, HSPC transduction, clinical signals, and pipeline analysis.
Article | Report Patent evidence maps the 2026 permanent magnet motor landscape: MTPA/MTPV control, variable magnetization, sensorless drives, and magnet health prognostics across EV, aerospace, and industrial domains.
Article | Report Patent-driven analysis of permanent magnet motor technology in 2026: rotor architecture, MTPA/MTPV control, sensorless drives, and magnet health monitoring trends.
Article | Report How TERN-701 and asciminib target the ABL myristoyl pocket to overcome T315I resistance in CML — patent landscape, ASCEMBL data, and pipeline analysis.
Article | Report 80+ patents mapped: discover how polymer science, active electronics, and biologics are reshaping the implantable drug delivery device landscape in 2026.
Article | Report Analyse 80+ patents (2000–2026) mapping implantable drug delivery device technology clusters, top assignees, application domains, and emerging directions for 2026.
Article | Report How tabelecleucel and allogeneic EBV-specific T cell therapy are reshaping the post-transplant lymphoproliferative disease pipeline. Patent analysis & clinical signals.
Article | Report How risdiplam validated RNA splicing as a drug target—and what next-generation ASO, RNAi, miRNA, and small-molecule approaches mean for ALS, AD, and beyond.
Article | Report Cellulose nanocomposite patents 2026: CNCs, CNFs, and bacterial cellulose in polymer matrices — key innovation clusters, assignees, and strategic IP signals.
Article | Report Survey of CAR-T cell patent activity targeting lupus, myositis, and systemic sclerosis — covering CD19, hypoimmunogenic platforms, CAR-Treg, and CAR-NK pipelines.
Article | Report How AI and machine learning reduce scrap rates in injection molding — from digital twin closed loops to real-time pressure control. Patent analysis of 25+ active filings.
Article | Report A deep-dive into the 2026 thermal interface material patent landscape: liquid metal TIMs, phase-change polymers, CNT composites, and emerging AI-driven formulation methods.
Article | Report How AI and machine learning reduce scrap rate in injection molding: digital twins, real-time pressure control, and multi-objective optimization explained with patent evidence.
Article | Report How IL-17A/F bispecific antibodies like bimekizumab are reshaping treatment of psoriasis, psoriatic arthritis, and hidradenitis suppurativa. Patent landscape analysis.